Intranasal Drug Delivery in Neuropsychiatry: Focus on Intranasal Ketamine for Refractory Depression

This will become a regular second line treatment in the near future, for major depressive illness Intranasal Drug Delivery in Neuropsychiatry: Focus on Intranasal Ketamine for Refractory Depression

A prospective observational study of ketamine for sedation of acutely agitated emergency department patients

#SAEM15 poster of ketamine for sedation of agitated ED patients. faster with similar side effects. @ketaminh @emcrit pic.twitter.com/30ySp4Wewt — jeff riddell (@Jeff__Riddell) May 20, 2015